Protein design 2026 Rank: #3036
LatentLabs ✓
Lab-ready protein binders in seconds.
Verdict
A quick read before you dig into the full page.
- Best if
- Lab-ready protein binders in seconds
- Skip if
- Dual-use biosecurity dimension
- Pick this when
- Designs antibodies, macrocycles, mini-proteins
Considering Latent-Y instead? Compare side by side
Overview
Latent-X is a frontier AI platform from Latent Labs for designing protein binders — antibodies, macrocycles, and mini-proteins — aimed at drug discovery.
From a target, it generates candidate binders the company reports achieve picomolar binding affinity, drug-like properties, and leading lab success rates, with results experimentally validated across multiple targets rather than only predicted in silico.
The site showcases lab-validated examples across all three modalities (antibodies against targets like IL-6, PD-L1, and MMP2; mini-binders against SARS-CoV-2 RBD, PD-L1, and others; macrocycles against MCL-1 and MDM2), and points to peer-style technical reports on arXiv for its Latent-X and Latent-Y models.
It's positioned to compress what is normally a long wet-lab discovery cycle into fast generative design of high-affinity, developable candidates. Access is gated behind account tiers and sign-in, aimed at researchers in biotech and pharma.
Access & connections
Where you can use LatentLabs, and what it plugs into.
Platforms
Integrations
Capabilities
What this tool accepts, produces, and is strongest at.
Supported features
- Medical
Pros & cons
Pros
- Designs antibodies, macrocycles, mini-proteins
- Reports picomolar binding affinity
- Experimentally lab-validated, not just predicted
- Emphasis on drug-like, developable properties
- Published technical reports (arXiv)
- Validated across many targets
- Compresses wet-lab discovery timelines
- Covers three binder modalities
Show 2 more
- Access-gated (KYC-friendly) platform
- Frontier-level stated success rates
Cons
- Dual-use biosecurity dimension
- Researcher/pharma audience only
- No public pricing (tiered, gated)
- Vendor-reported metrics need independent validation
- Requires deep domain expertise
- Wet-lab still needed downstream
- Narrow, specialized use case
- Access approval likely required
Show 2 more
- Little operator detail on this page
- High-stakes outputs, careful oversight needed
Compare alternatives
Similar tools in the catalog — with a clear reason to open each one.
Latent-Y ✓
UnknownDesign antibodies from text prompts in hours, not weeks.
No pricing
Full comparison
PatchDesign.AI ✓
FreemiumDesign custom patches in seconds using AI.
Why look Offers a public API
Full comparisonPIQAPART ✓
Free TrialFrom video or photos to a manual in seconds.
Free + from $317/mo
Full comparison